Widespread alterations in the peripheral blood innate immune cell profile in cystic fibrosis reflect lung pathology.
Emily M MulcahyMargaret A CooleyHelen Marie McGuireSuzanne AsadBarbara Fazekas de St GrothSean A BeggsLouise F RoddamPublished in: Immunology and cell biology (2019)
Cystic fibrosis (CF) is caused by mutations to the CF transmembrane conductance regulator (CFTR) gene. CFTR is known to be expressed on multiple immune cell subtypes, dendritic cells, monocytes/macrophages, neutrophils and lymphocytes. We hypothesized that the lack of CFTR expression on peripheral blood innate immune cells would result in an altered cell profile in the periphery and that this profile would reflect lung pathology. We performed a flow cytometric phenotypic investigation of innate immune cell proportions in peripheral blood collected from 17 CF patients and 15 age-matched healthy controls. We observed significant differences between CF patients and controls in the relative proportions of natural killer (NK) cells, monocytes and their subsets, with significant correlations observed between proportions of NK and monocyte cell subsets and lung function (forced expiratory volume in 1 sec, % predicted; FEV1% predicted) in CF patients. This study demonstrates the widespread nature of immune dysregulation in CF and provides a basis for identification of potential therapeutic targets. Modulation of the distinct CF-related immune cell phenotype identified could also be an important biomarker for evaluating CFTR-targeted drug efficacy.
Keyphrases
- cystic fibrosis
- peripheral blood
- lung function
- pseudomonas aeruginosa
- end stage renal disease
- dendritic cells
- ejection fraction
- chronic kidney disease
- immune response
- newly diagnosed
- single cell
- poor prognosis
- stem cells
- nk cells
- climate change
- cell therapy
- patient reported outcomes
- drug delivery
- risk assessment
- patient reported
- intensive care unit
- innate immune
- regulatory t cells
- human health